Share
Asaf Azulay
Polyrizon Ltd., a biotech company specializing in intranasal hydrogels, has appointed Asaf Azulay as its VP of Regulatory Affairs and Quality Assurance (RA/QA).
Azulay, currently Managing Director of Eurofins’ Li-Med team, brings over 20 years of experience in the medical devices industry, with expertise in quality management, regulatory compliance, and strategic leadership.
This appointment underscores Polyrizon’s commitment to meeting the highest industry standards as it advances its pipeline of innovative intranasal therapies.
With regulatory requirements becoming increasingly stringent, Azulay’s deep understanding of the global regulatory landscape will be instrumental in ensuring compliance, streamlining approval processes, and prioritizing patient safety.
His leadership will strengthen Polyrizon’s ability to navigate regulatory complexities, accelerating the company’s path to market and enhancing its mission to deliver breakthrough intranasal solutions worldwide.
